Rhabdoviruses as vaccine platforms for infectious disease and cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rhabdoviruses as vaccine platforms for infectious disease and cancer

Published:2018-01-02 Issue:1 Volume:34 Page:122-138
ISSN:0264-8725
Container-title:Biotechnology and Genetic Engineering Reviews
language:en
Short-container-title:Biotechnology and Genetic Engineering Reviews

Author:

Zemp Franz¹²,Rajwani Jahanara¹²³,Mahoney Douglas J.¹²⁴³

Affiliation:

1. Alberta Children’s Hospital Research Institute, Calgary, Canada

2. Charbonneau Cancer Research Institute, Calgary, Canada

3. Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, Canada

4. Department of Microbiology, Immunology and Infectious Disease, Faculty of Medicine, University of Calgary, Calgary, Canada

Publisher

Informa UK Limited

Subject

Molecular Biology,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02648725.2018.1474320

Reference68 articles.

1. Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

2. Customized Viral Immunotherapy for HPV-Associated Cancer

3. Phenotypic Consequences of Rearranging the P, M, and G Genes of Vesicular Stomatitis Virus

4. Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity

5. Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir;npj Viruses;2024-06-24

2. A Method for the Production of Recombinant VSVs with Confirmation of Biological Activity;Acta Naturae;2024-05-10

3. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer;Molecular Therapy;2024-01

4. Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy;International Journal of Molecular Sciences;2023-12-22

5. Identification of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir;2023-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3